Financials Healthcare Realty Trust Incorporated

Equities

HR

US42226K1051

Specialized REITs

End-of-day quote Nyse 06:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
14.38 USD 0.00% Intraday chart for Healthcare Realty Trust Incorporated +3.01% -16.54%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 4,463 4,027 4,668 7,334 6,562 5,395 - -
Enterprise Value (EV) 1 5,894 5,634 6,479 7,334 11,532 10,033 10,442 10,632
P/E ratio 115 x 56.9 x 70.3 x 128 x -23.3 x -31.2 x -35 x -46.1 x
Yield 3.6% 4.05% 3.82% 6.43% 7.2% 8.77% 8.77% 8.77%
Capitalization / Revenue 9.49 x 8.06 x 8.73 x 7.86 x 4.88 x 4.08 x 3.95 x 3.89 x
EV / Revenue 12.5 x 11.3 x 12.1 x 7.86 x 8.58 x 7.59 x 7.64 x 7.66 x
EV / EBITDA 23.2 x 20.9 x 22.5 x 13.7 x 14.7 x 12.8 x 12.9 x 12.9 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 2.37 x 2.12 x 2.18 x 0.97 x 0.96 x 0.88 x 0.97 x -
Nbr of stocks (in thousands) 133,736 136,054 147,542 380,572 380,874 381,513 - -
Reference price 2 33.37 29.60 31.64 19.27 17.23 14.14 14.14 14.14
Announcement Date 2/12/20 2/10/21 2/22/22 3/1/23 2/16/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 470.3 499.6 534.8 932.6 1,344 1,322 1,367 1,387
EBITDA 1 253.7 269.8 288.4 535.9 784.9 780.9 810 821.6
EBIT 1 75.87 79.42 85.68 82.78 54.22 63.33 91.81 104.9
Operating Margin 16.13% 15.89% 16.02% 8.88% 4.03% 4.79% 6.72% 7.56%
Earnings before Tax (EBT) 1 - - 66.66 - -282.1 -177 -142 -118
Net income 1 39.18 72.2 66.66 40.9 -278.3 -174.9 -156.9 -118
Net margin 8.33% 14.45% 12.46% 4.39% -20.71% -13.23% -11.48% -8.51%
EPS 2 0.2900 0.5200 0.4500 0.1500 -0.7400 -0.4533 -0.4040 -0.3066
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 1.200 1.200 1.210 1.240 1.240 1.240 1.240 1.240
Announcement Date 2/12/20 2/10/21 2/22/22 3/1/23 2/16/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 136.6 136.4 142.9 145.3 306.4 338.1 332.9 338.1 342.3 330.4 325.5 327.8 331.7 334.9 339
EBITDA 1 72.91 74.49 74.39 77.78 177.1 206.6 196 197.3 197.2 194.5 191.8 193.6 193.9 198.1 200.5
EBIT 1 - 22.68 20.35 22.05 19.02 21.36 11.47 14.09 14.24 14.42 9.601 11.09 14.42 20.6 22.75
Operating Margin - 16.63% 14.24% 15.17% 6.21% 6.32% 3.45% 4.17% 4.16% 4.36% 2.95% 3.38% 4.35% 6.15% 6.71%
Earnings before Tax (EBT) 1 - - - - - - - - - -41.68 -48.63 -45.31 -43.17 -39.9 -40.28
Net income 1 -2.066 21.61 42.23 6.13 28.3 -35.76 -87.12 -82.76 -67.84 -40.53 -47.87 -44.8 -44.78 -41.42 -39.88
Net margin -1.51% 15.84% 29.55% 4.22% 9.24% -10.58% -26.17% -24.47% -19.82% -12.27% -14.71% -13.67% -13.5% -12.37% -11.76%
EPS 2 -0.0200 0.1400 0.2800 0.0400 0.0800 -0.2000 -0.2300 -0.2200 -0.1800 -0.1100 -0.1269 -0.1190 -0.1191 -0.1085 -0.1012
Dividend per Share 2 0.3025 0.3025 0.3100 0.3100 0.3100 0.3100 0.3100 0.3100 0.3100 0.3100 0.3100 0.3100 0.3100 0.3100 0.3100
Announcement Date 11/3/21 2/22/22 5/5/22 8/9/22 11/9/22 3/1/23 5/9/23 8/8/23 11/3/23 2/16/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,431 1,606 1,811 - 4,969 4,639 5,047 5,237
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 5.642 x 5.953 x 6.279 x - 6.331 x 5.94 x 6.232 x 6.375 x
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 2.17% 3.75% 3.23% 0.84% -2.17% -2.93% -2.81% -2.86%
ROA (Net income/ Total Assets) 1.16% 1.96% 1.65% - -2.1% -1.55% -1.33% -1.09%
Assets 1 3,377 3,688 4,036 - 13,244 11,271 11,764 10,814
Book Value Per Share 2 14.10 14.00 14.50 19.90 17.90 16.00 14.60 -
Cash Flow per Share - - 1.630 1.070 - - - -
Capex - - - - 231 - 100 100
Capex / Sales - - - - 17.19% - 7.32% 7.21%
Announcement Date 2/12/20 2/10/21 2/22/22 3/1/23 2/16/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
14.14 USD
Average target price
16.33 USD
Spread / Average Target
+15.51%
Consensus
  1. Stock Market
  2. Equities
  3. HR Stock
  4. Financials Healthcare Realty Trust Incorporated